Emily writes frequently about autism and related issues, and her work has appeared in print or online at Discover, New York Times, Slate, Washington Post, San Francisco Chronicle, and others. Emily has a B.A. in English with minors in German and History and a Ph.D. in biological sciences, both from The University of Texas at Austin. She also completed postdoctoral work at the University of California, San Francisco and has taught graduate and undergraduate biology for many years.
Emily Willingham
Science writer
Spectrum
From this contributor
The legacy of Steve Silberman and his book, ‘NeuroTribes’
The writer’s empathic storytelling changed how society—and researchers—view autistic people.
The legacy of Steve Silberman and his book, ‘NeuroTribes’
By
Emily Willingham
26 September 2024 | 8 min read
Spotted around the web: Week of 29 October 2018
Here is a roundup of news and research for the week of 29 October.
Spotted around the web: Week of 29 October 2018
By
Emily Willingham
2 November 2018 | 5 min read
Book Review: A mother finds reward in risk
In “The Boy Who Loved Too Much,” a woman tries to cocoon her son, who has Williams syndrome, from life’s insults but later realizes her protective instincts carry dangers of their own.
Book Review: A mother finds reward in risk
By
Emily Willingham
30 October 2018 | 5 min read
Spotted around the web: Week of 22 October 2018
Here is a roundup of news and research for the week of 22 October.
Spotted around the web: Week of 22 October 2018
By
Emily Willingham
26 October 2018 | 4 min read
Spotted around the web: Week of 15 October 2018
Here is a roundup of news and research for the week of 15 October.
Spotted around the web: Week of 15 October 2018
By
Emily Willingham
19 October 2018 | 4 min read
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read